Table 4:
Adverse events
Adverse Events
Embolization to distal or a new territory (%)
15.7
Hemorrhagic conversion (%)
22.9
Symptomatic hemorrhagic conversion (%)
4.3
Mortality in follow-up period (%)
11.4